Strategic Advocates LLC Dexcom Inc Call Options Transaction History
Strategic Advocates LLC
- $279 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DXCM
# of Institutions
1,029Shares Held
355MCall Options Held
3.81MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.44 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.5 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.3 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.21 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.09 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $28B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...